Get access

Survey on cannabis use in Parkinson's disease: Subjective improvement of motor symptoms

Authors

  • Kateřina Venderová PharmD, PhD,

    1. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
    Search for more papers by this author
  • Evžen Růžička MD, DSc,

    Corresponding author
    1. Movement Disorders Centre, Department of Neurology, 1st Medical Faculty, Charles University, Prague, Czech Republic
    • Movement Disorders Centre, Department of Neurology, 1st Medical Faculty, Charles University, Prague, Czech Republic
    Search for more papers by this author
  • Viktor Voříšek PharmD,

    1. Division of Clinical Toxicology and Mass Spectrometry, Department of Biochemistry, University Hospital Hradec Králové, Czech Republic
    Search for more papers by this author
  • Peter Višňovský MD, PhD

    1. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
    Search for more papers by this author

Abstract

An anonymous questionnaire sent to all patients attending the Prague Movement Disorder Centre revealed that 25% of 339 respondents had taken cannabis and 45.9% of these described some form of benefit. © 2004 Movement Disorder Society

Ancillary